Yedid Elbez

机构：MRC Biostatistics Unit, Hôpital Bichat-Claude-Bernard · ORCID：0000-0002-1883-8632

发表论文 107 篇 · 总被引 1561 次 · h-index 19

代表论文

• Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial (2022 · Dermatology and Therapy · 被引 49)
• Prediction of flare following remission and treatment withdrawal in early rheumatoid arthritis: post hoc analysis of a phase IIIb trial with abatacept (2022 · Arthritis Research & Therapy · 被引 18)
• New-onset atrial fibrillation and chronic coronary syndrome in the CLARIFY registry (2023 · European Heart Journal · 被引 17)
• Alirocumab and Cardiovascular Outcomes in Patients With Previous Myocardial Infarction: Prespecified Subanalysis From ODYSSEY OUTCOMES (2022 · Canadian Journal of Cardiology · 被引 14)
• Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) registry (2021 · International Journal of Cardiology · 被引 13)
• Chronic coronary syndromes without standard modifiable cardiovascular risk factors and outcomes: the CLARIFY registry (2024 · European Heart Journal · 被引 8)